Antibiotic Prices In China Keep Falling Ahead Of New Regulations
This article was originally published in PharmAsia News
Members of the China API Conference revealed that in the face of regulatory uncertainties and price competition with India, antibiotic makers in China have been cautious about buying APIs, and certain antibiotic materials have been in short supply
You may also be interested in...
Work and movement-related restrictions are affecting the ability of companies to provide a timely response to questions relating to their prequalification dossiers.
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.